Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
35.98
-0.31 (-0.85%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Collegium Pharmaceutical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Collegium Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $53.6. The average 1-year stock price forecast is 48.97% higher than the current stock price, while the lowest is $45 (+25.07%) and the highest is $60 (+66.76%).
Price Target: $53.6 (+48.97%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 1, 2026.
Analyst Ratings
The average analyst rating for Collegium Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $56 | Buy | Maintains | $56 | +55.64% | Jul 1, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Needham | Needham | Buy Maintains $56 | Buy | Maintains | $56 | +55.64% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +66.76% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $44 | Hold | Maintains | $44 | +22.29% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
869.86M
from 780.57M
Increased by 11.44%
Revenue Next Year
860.15M
from 869.86M
Decreased by -1.12%
EPS This Year
7.76
from 7.42
Increased by 4.65%
EPS Next Year
7.50
from 7.76
Decreased by -3.35%
EPS and Forward PE are based on non-GAAP adjusted numbers.